Drug name - Emend

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8258132 MSD MERCK CO Pharmaceutical composition of a tachykinin receptor antagonist Sep, 2027

(4 years from now)

Drugs and Companies using APREPITANT ingredient

Treatment: Prevention of nausea and vomiting associated with chemotherapy (cinv)

Dosage: FOR SUSPENSION;ORAL

More Information on Dosage
Strength Dosage Availability
125MG/KIT FOR SUSPENSION;ORAL Prescription
Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US8258132 MERCK Pharmaceutical composition of a tachykinin receptor antagonist Sep, 2027

(4 years from now)

Drugs and Companies using APREPITANT ingredient

Treatment: Prevention of postoperative nausea and vomiting; for the prevention of nausea and vomiting associated with chemotherapy

Dosage: CAPSULE;ORAL

More Information on Dosage
Strength Dosage Availability
40MG CAPSULE;ORAL Discontinued
80MG CAPSULE;ORAL Prescription
125MG CAPSULE;ORAL Prescription

availability in other generic markets.

Click on the highlighted region to filter.